<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04249505</url>
  </required_header>
  <id_info>
    <org_study_id>ABCD RefAcc</org_study_id>
    <nct_id>NCT04249505</nct_id>
  </id_info>
  <brief_title>Refractive Accuracy of &quot;2WIN&quot; and Portable Autorefractors</brief_title>
  <official_title>The Refractive Accuracy of Photoscreeners &quot;2WIN&quot; and &quot;PlusoptiX&quot; and the &quot;Retinomax&quot; Auto Refractor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alaska Blind Child Discovery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alaska Blind Child Discovery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Youth and some adults have photoscreening refractions and hand-held auto refraction before
      cycloplegia refraction during new and follow up eye examinations. Vector math is applied to
      each refraction to determine how closely the hand-held &quot;dry&quot; devices match actual refraction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A closeness-of-fit algorithm utilizing vector transformations of astigmatism is designed and
      applied to 50-years of clinical international refractive experience.

      As a part of new and follow up comprehensive eye examinations, patients and parents consented
      to confirm the cycloplegic refraction to other portable refractive tools.

      The ability of photoscreeners &quot;2WIN&quot; (&quot;Adaptica,&quot; Padova italy), &quot;PlusoptiX A12&quot; (Nuremberg,
      Germany) and &quot;Retinomax&quot; (Righton, Tokyo, Japan) to match actual refraction is assessed
      utilizing the new algorithm.

      This algorithm could then be applied to batches of donated spectacles distend by charitable
      organizations worldwide if portable auto refracting devices are employed.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 9, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Refractive Accuracy</measure>
    <time_frame>1 day</time_frame>
    <description>spherical equivalent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Refractive Accuracy</measure>
    <time_frame>1 day</time_frame>
    <description>Vector transform J0 and J45 astigmatism</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Refractive Accuracy</measure>
    <time_frame>1 day</time_frame>
    <description>Spectacle comparison score (Percent similarity combined sphere-cylinder)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of age</measure>
    <time_frame>1 day</time_frame>
    <description>Spectacle similarity score striated by age relative to patient's ability to accommodate</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Refractive Error - Myopia Axial</condition>
  <condition>Astigmatism</condition>
  <condition>Accomodation</condition>
  <condition>Visual Impairment</condition>
  <condition>Hyperopia of Both Eyes</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>&quot;2WIN&quot; Photoscreener</intervention_name>
    <description>non-cycloplegia refraction by Adaptica &quot;2WIN&quot;</description>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>&quot;Plusoptix A12&quot;</intervention_name>
    <description>non-cycloplegic refraction by &quot;Plusoptix A12&quot; photoscreener</description>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>&quot;Retinomax&quot;</intervention_name>
    <description>non-cycloplegic refraction by &quot;Retinomax K+&quot; auto refractor</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        children and adults attending pediatric ophthalmology and adult strabismus clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient undergoing new or follow examination at pediatric eye and adult strabismus
             clinic Willing to undergo screening refractive device developmental delays included

        Exclusion Criteria:

          -  Intraocular lens in place
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bob Arnold, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Coordinator Alaska Blind Child Discovery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alaska Children's EYE &amp; Strabismus</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Arnold SL, Arnold AW, Sprano JH, Arnold RW. Performance of the 2WIN Photoscreener With &quot;CR&quot; Strabismus Estimation in High-Risk Patients. Am J Ophthalmol. 2019 Nov;207:195-203. doi: 10.1016/j.ajo.2019.04.016. Epub 2019 May 9.</citation>
    <PMID>31077668</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>January 29, 2020</study_first_submitted>
  <study_first_submitted_qc>January 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2020</study_first_posted>
  <last_update_submitted>July 9, 2020</last_update_submitted>
  <last_update_submitted_qc>July 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>photoscreening</keyword>
  <keyword>photo refraction</keyword>
  <keyword>auto refraction</keyword>
  <keyword>spectacle dispensing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vision Disorders</mesh_term>
    <mesh_term>Vision, Low</mesh_term>
    <mesh_term>Astigmatism</mesh_term>
    <mesh_term>Refractive Errors</mesh_term>
    <mesh_term>Hyperopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>de-identified database shared on www.ABCD-Vision.org Website.</ipd_description>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>after study completed</ipd_time_frame>
    <ipd_access_criteria>open</ipd_access_criteria>
    <ipd_url>http://www.abcd-vision.org/references/index.html</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

